ArticleThe Journal of pharmacology and experimental therapeutics2010

Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides.

Byung-Joon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.